Protocol · Training
Resistance training, minimum effective dose
Strength, muscle mass, and physical function gains
Evidence type: Randomized trials
The graded dose: Muscle-strengthening activity, progressive, full-body; the named dose is the minimum: about 60 min/week total across 2 sessions (cohort risk reduction peaks at roughly 30 to 60 min/week). Frequency in the evidence: 2 sessions per week. The grade attaches to this dose; below it, the grade does not apply.
The caveat: The mortality claim is cohort evidence and grades B+; the headline rests on the randomized trial base.
Time cost
60 minutes / week
At the named minimum dose.
Dollar cost
About $40 / month
Free to home-basic at the minimum dose for beginners; facility $40 to $100/mo; adjustable dumbbells or kettlebells $150 to $500 one-time (basis: facility | home-device)
Every claim, graded
Each outcome this protocol is claimed to deliver carries its own grade and its own kind of evidence. A strong secondary outcome never launders a weak popular claim: the popular claim prints at its own grade, next to the headline.
| Claim | Grade | Evidence | What the data show |
|---|---|---|---|
| Strength, muscle mass, physical function, and glycemic control gains | A- | rctRandomized trials | Progressive resistance training reliably increases strength and lean mass and improves glycemic markers across hundreds of RCTs and multiple meta-analyses, the deepest RCT base of any training entry in the inventory. Effect sizes vary by population and program; the protein target record (1.6 g/kg/day) is the documented interaction.Meta-analyses of resistance training RCTs |
| Lower all-cause and cause-specific mortality | B+ | cohortCohort (observational) | Momma 2022 (BJSM): meta-analysis of 16 cohorts; any muscle-strengthening activity associated with 10 to 17% lower risk of all-cause mortality, cardiovascular disease, total cancer, and diabetes; maximum reduction (about 10 to 20%) at roughly 30 to 60 min/week, J-shaped beyond about 140 min/week. Combined with aerobic activity: about 40% lower all-cause mortality vs neither. No mortality RCT exists; cohort cap applies.Momma H et al., British Journal of Sports Medicine, 2022 |
Dose and response
The mortality association peaks at about 30 to 60 min/week and the curve is J-shaped: benefit is unclear and possibly fades beyond about 140 min/week (Momma 2022). The page says this out loud: more is not automatically better at the mortality outcome. Strength and function gains, by contrast, scale with progressive training beyond the minimum.
Equipment that can deliver this dose: Basic home setup, Home device, Facility.
Harms and cautions
Harms live in this ledger, not inside the grade: the grade is evidence for the claimed outcomes in the studied population.
Medication interactions
No medication classes are flagged in this graded record.
Goal conflicts and timing
No goal conflicts in this record.
Sessions on non-consecutive days for the same muscle groups (about 48 hours) is the ACSM-consistent convention; the cohort dose itself carries no timing.
Population exclusions and other cautions
Musculoskeletal injury, load and technique dependentcaution
Technique coaching advisable for loaded compound lifts
Source: Longevity Lab Report evidence review, 2026-10-18
Rhabdomyolysis (rare)serious
Extreme novel volume in deconditioned users
Source: Longevity Lab Report evidence review, 2026-10-18
Blood pressure spikes during maximal liftingcaution
Uncontrolled hypertension: clinician conversation before maximal lifting
Source: Longevity Lab Report evidence review, 2026-10-18
Can you measure it yourself?
Strength, muscle mass, physical function, and glycemic control gains
- Metric
- Anchor-lift performance (load x reps at fixed form on 2 to 3 lifts, or a 5-rep-max estimate); grip strength as secondary
- Method
- Fixed-form anchor lifts; dynamometer for grip
- Baseline
- Two sessions in week 1
- Minimum run
- 4 weeks; retest: Every 4 weeks
Noise note: Early gains are partly neural learning, and day-to-day strength varies about 5%; act on a consistent 5 to 10% trend (grip: 2 kg or more over 8 weeks).
Outcomes without a measurement block carry none because no effect is established for them: a self-experiment cannot test a claim the evidence has not made.
Related graded records
- Protein intake target (1.6 g/kg/day) →
The documented interaction: this record's trial summary names the protein target as the pairing that sizes the augmentation.
Goals served
Muscle and strength, Longevity
Derived from outcomes grading B- or better, never hand-assigned.
Experience gate
beginner and up (gated for skill)
Applicability
broad
Applies broadly, across goals and populations.
Grades are research summaries, not medical advice. Decisions about your own stack belong with your clinician.
Longevity Lab Report
Protocol news, graded when it happens.
The grades on this page stay free. The email is the week's longevity and biotech news in plain English: biotech news, expert moves, what is working, and new supplements and peptides, each story linked to the grades on this site.
Frequently asked questions
What grade does Resistance training, minimum effective dose get?
At the studied dose (about 60 minutes a week across 2 sessions), Resistance training, minimum effective dose grades A- for strength, muscle mass, and physical function gains, on randomized trials. The grade attaches to that dose; below it, the grade does not apply.
How much time does Resistance training, minimum effective dose take each week?
At the graded dose, 60 minutes per week, counted as session time plus standard overhead, travel excluded. Dollar cost: Free to home-basic at the minimum dose for beginners; facility $40 to $100/mo; adjustable dumbbells or kettlebells $150 to $500 one-time.
Who should not use Resistance training, minimum effective dose?
Rhabdomyolysis (rare). Extreme novel volume in deconditioned users. The full harm ledger is on this page, and the medical line applies: decisions about your own stack belong with your clinician.
Sources
- Momma H et al. Muscle-strengthening activities are associated with lower risk and mortality. BJSM, 2022. (2022)
Last reviewed October 18, 2026
- 2026-10-18|Initial grading from the 2026-10-18 protocol inventory evidence review.
- 2026-10-18|Update: goal assignments are now recorded for each outcome individually, not only for the record as a whole. No grades, doses, or claims changed.